Galen shares rise by 3.81%
Fourth-quarter profits jumped almost sevenfold as demand increased for its birth control and premenstrual syndrome pills.
Net income increased to $33.9 million, or 18.4 cents a share, in the three months ended September 30, from $4.9 million, or 2.7 cents, in the same period last year.